Every day, we seem to witness the theater of high-stakes negotiations between the United States and China. Just a few days ago, the President announced a new 100 percent tariff on Chinese imports—only to reconsider shortly after. It’s easy to tune out this back-and-forth, but in truth, we can’t afford to. The consequences reach far beyond politics and headlines—they reach directly into America’s hospitals, clinics, and homes.

Understanding Tariffs and Their Impact

A tariff is essentially a tax on imported or exported goods. In most cases, the cost of that tax is passed down the supply chain, meaning that buyers—rather than suppliers—end up paying more for the same products. In healthcare, this translates to higher costs for hospitals and other providers, and ultimately higher costs for patients.

Economists generally agree that tariffs are harmful to the broader economy. They raise consumer prices, reduce trade (for example, China imported no U.S. soybeans in September for the first time in seven years, according to Reuters), and often prompt retaliatory actions from trading partners. While tariffs can offer short-term protection to certain domestic industries, they tend to create inefficiencies, discourage investment, and slow economic growth. In short, they distort markets rather than strengthen them.

Why China Matters to U.S. Healthcare

So, why should healthcare leaders care about China? Well, because China is a critical link in the global medical supply chain. In 2018, the U.S. imported more than $29 billion in medical equipment, with China supplying roughly 28% of that total. By 2024, U.S. pharmaceutical imports from China reached about $7.84 billion.

For many consumable supplies—such as gloves, gowns, dressings, and syringes—China is the dominant source. Some analysts suggest that more than half of the U.S. supply of these basic medical goods comes from Chinese producers. When it comes to capital equipment like imaging systems and surgical devices, China’s role is smaller (around 14% of devices sold in the U.S.) but still significant.

Because medical supply chains are both global and lean, disruptions in China—whether due to tariffs, logistics challenges, or export restrictions—can quickly ripple through the U.S. healthcare system. The COVID-19 pandemic demonstrated this vulnerability in stark terms: shortages of PPE, masks, and basic medical equipment revealed how dependent we had become on a limited number of overseas suppliers.

The Bigger Picture

To be clear, the U.S. is not wholly dependent on China. About 70% of medical equipment used here is domestically produced, and other countries such as Germany, Ireland, and Mexico play major roles in the supply chain. Still, China remains indispensable in many categories of essential medical products.

As trade tensions escalate, healthcare organizations must prepare for continued volatility. Tariffs and national-security reviews may eventually shift sourcing and production patterns, but in the near term, one thing is certain: the cost of care will continue to rise.